CIK 0000093314
- Non-accelerated filer
- Smaller reporting company
VOLITIONRX LTD
Sign in to watch- Ticker
- VNRX
- Exchange
- NYSE
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 911949078
- Phone
- +1 512-774-8930
- Business address
- 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON, NV, 89014
- Former names
- VOLITIONRX LTD, STANDARD CAPITAL CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-01 | Rootsaert Rodney Gerard Secretary | Grant or award | +7,908 | 143,026 | ||
| 2025-03-01 | Plummer Nicholas GC - Volition Diagnostics | Grant or award | +12,483 | 177,628 | ||
| 2025-03-01 | Nguyen Kim Director | Grant or award | +9,893 | 86,409 | ||
| 2025-03-01 | Batchelor Ann-Louise Group Chief Marketing Officer | Grant or award | +14,233 | 128,942 | ||
| 2025-03-01 | Colman Alan Director | Grant or award | +14,840 | 245,364 | ||
| 2025-03-01 | Kway Jasmine CEO - Singapore Volition | Grant or award | +16,708 | 182,780 | ||
| 2025-03-01 | Retter Andrew Chief Medical Officer | Grant or award | +10,142 | 137,617 | ||
| 2025-03-01 | Rubin Ethel Director | Grant or award | +9,893 | 33,541 | ||
| 2025-03-01 | Butera Salvatore Thomas CEO - Volition Veterinary | Grant or award | +19,300 | 312,890 | ||
| 2025-03-01 | Forterre Gael Chief Commercial Officer | Grant or award | +5,523 | 162,704 | ||
| 2025-03-01 | Innes Guy Archibald Director | Grant or award | +19,786 | 686,871 | ||
| 2025-03-01 | Hughes Terig Chief Financial Officer | Grant or award | +13,969 | 390,221 | ||
| 2025-01-29 | Colman Alan Director | Returned to the company · Stock Option (Right to Buy) | −25,000 | 0 | ||
| 2025-01-29 | Colman Alan Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2025-01-29 | Reynolds Cameron John President and CEO | Returned to the company · Stock Option (Right to Buy) | −50,000 | 0 | ||
| 2025-01-29 | Reynolds Cameron John President and CEO | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2025-01-29 | Innes Guy Archibald Director | Returned to the company · Stock Option (Right to Buy) | −25,000 | 0 | ||
| 2025-01-29 | Innes Guy Archibald Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2025-01-29 | Kway Jasmine CEO -Singapore Volition | Returned to the company · Stock Option (Right to Buy) | −50,000 | 0 | ||
| 2025-01-29 | Kway Jasmine CEO -Singapore Volition | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 |
Page 7 of 11 · 216 trades